Section Arrow
Quote
CDNA.NASDAQ
- CareDx
Quotes are at least 15-min delayed:2026/03/30 06:06 EDT
Pre Market
Last
 17.01
+0.23 (+1.37%)
Bid
16.48
Ask
17.28
High 17.07 
Low 16.68 
Volume 86 
Regular Hours (Closed)
Last
 16.78
-0.69 (-3.95%)
Day High 
17.465 
Prev. Close
17.47 
1-M High
19.33 
Volume 
551.53K 
Bid
16.48
Ask
17.28
Day Low
16.54 
Open
17.34 
1-M Low
16.27 
Market Cap 
898.53M 
Currency 美元 
P/E 13.98 
%Yield -- 
10-SMA 17.5 
20-SMA 17.77 
50-SMA 19.05 
52-W High 21.485 
52-W Low 10.96 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.40/-0.15
Enterprise Value
918.21M
Balance Sheet
Book Value Per Share
5.92
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
333.79M
Operating Revenue Per Share
5.78
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
DHRDanaher Corp181.52-6.13-3.27%37.31PE
Pre Market 181.88 +0.36 +0.20%
OPKOPKO Health1.12-0.05-4.27%-- 
Pre Market 1.113 -0.007 -0.63%
PSNLPersonalis6.34-0.98-13.39%-- 
Pre Market 6.36 +0.02 +0.32%
BIAFbioAffinity Technologies Inc4-0.74-15.61%-- 
Pre Market 4.0456 +0.0456 +1.14%
SHCSotera Health Company13.13-0.41-3.03%50.15PE
Pre Market -- -- --
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.